Results 71 to 77 of about 3,625 (77)

Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

Nano Letters, 2019
Yongzhuo Huang, Qin Xu
exaly  

Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma

ACS Applied Materials & Interfaces, 2017
Victoria Wu, Vuk Uskoković
exaly  

The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling

Journal of Cellular Biochemistry, 2017
Huan-Tian Zhang, Guihong Liang, Qing-Yu He   +2 more
exaly  

EGFR‐mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1

Journal of Cellular Biochemistry, 2018
Dongdong Tong
exaly  

Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1

ACS Medicinal Chemistry Letters
Kevin Mackenzie, Martin Matzuk, Damian Young   +2 more
exaly  

The BET inhibitor JQ1 targets fat metabolism and counteracts obesity

Journal of Advanced Research
Massimo Collino, Raffaella Mastrocola, Giuseppina Caretti   +2 more
exaly  

Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy

Bioorganic and Medicinal Chemistry
exaly